Where is Palvella headquartered?

Palvella is located in Wayne, PA.

Who invested in Palvella?

Palvella has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Palvella?

Palvella closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

palvellatx.com

Palvella

Palvella is a Pennsylvania-based biotechnology company that researches and develops novel therapeutics for the treatment of genetic skin diseases.

Business Model:

Revenue: $1.5M

Employees: 11-50

Geographic Data

Address: 125 Strafford Avenue

City: Wayne

State: PA

Zip: 19087

Country: US

Financial Info

Stage:

series c

Raised Last:

$45M

Raised Total:

$59M

Social

Crunchbase

Metrics

4,828,744Website Global Rank

1,866Website Monthly Traffic

Twitter Followers

Description

Palvella is a Pennsylvania-based biotechnology company that researches and develops novel therapeutics for the treatment of genetic skin diseases.

Contact Phone:
+14842531461

Contact Email:

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
12/2022	Series D		$37.7M	Petrichor Gore Range Capital Samsara BioCapital BVF Partners L.P Agent Capital Nolan Capital BioAdvance
12/2018	Corporate Round	1	$10M	Ligand Pharmaceuticals Ligand Pharmaceuticals
12/2022	Venture Round		$9.7M
1/2023	Series D	7	$37.7M	Samsara BioCapital Petrichor Healthcare Capital Management Nolan Capital Gore Range Capital BVF Partners BioAdvance Agent Capital Samsara BioCapital Petrichor Healthcare Capital Management Nolan Capital Gore Range Capital BVF Partners BioAdvance Agent Capital
3/2019	Equity		$4.8M
6/2018	Venture Round		$4.4M
5/2020	Series C		$45M	CAM Capital Samsara BioCapital BVF Partners L.P Adams Street Partners Ligand Pharmaceuticals Agent Capital BioAdvance Nolan Capital
8/2017	Venture Round	2	-	13 Ventures BioAdvance 13 Ventures BioAdvance
5/2018	Equity		$4.4M
5/2020	Series C		$0	Adams Street Partners Agent Capital BioAdvance BVF Partners CAM Capital Ligand Pharmaceuticals Nolan Capital Opaleye Management Samsara BioCapital Adams Street Partners Agent Capital BioAdvance BVF Partners CAM Capital Ligand Pharmaceuticals Nolan Capital Opaleye Management Samsara BioCapital
5/2020	Series C	9	$45M	Adams Street Partners Agent Capital BioAdvance BVF Partners CAM Capital Ligand Pharmaceuticals Nolan Capital Opaleye Management Samsara BioCapital Adams Street Partners Agent Capital BioAdvance BVF Partners CAM Capital Ligand Pharmaceuticals Nolan Capital Opaleye Management Samsara BioCapital
8/2017	Venture Round	2	-	13 Ventures BioAdvance 13 Ventures BioAdvance

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details